首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1455781

全球油菜籽卵磷脂市場 - 2023-2030

Global Rapeseed Lecithin Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 209 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球油菜籽卵磷脂市場達到2.102億美元，預計2030年將達到3.638億美元，2023-2030年預測期間CAGR為7.1%。

近年來，消費者對各行業天然、永續和有用成分的需求不斷成長，推動了全球油菜籽卵磷脂市場的穩定成長。菜籽卵磷脂源自菜籽油，作為乳化劑、穩定劑和分散劑，為食品、製藥、化妝品和工業應用提供了適應性強的選擇。

根據 foodInsight 出版物，最近的資料估計，全球 1.1% 至 10.8% 的人口患有食物過敏，食物過敏率似乎正在上升。由於消費者對產品的成分越來越挑剔並且注重健康，油菜籽卵磷脂的非基因改造和無過敏原特性使其成為大豆和向日葵卵磷脂等更傳統來源的理想替代品。

非基因改造油菜籽卵磷脂在全球油菜籽卵磷脂市場中佔有最大的市場佔有率。同樣，亞太地區在油菜籽卵磷脂市場上佔據主導地位，佔據最大市場佔有率，超過 1/3。隨著該地區的美容和個人護理行業不斷創新和多元化，油菜籽卵磷脂提供了一種理想的成分選擇，可以滿足監管要求和消費者對功效、安全性和環境責任的期望。

動力學

對非基因改造和無過敏原成分的需求不斷增加

消費者越來越關注食品、藥品、化妝品和工業產品中使用的成分，從而偏好清潔標籤和不含基因改造生物 (GMO) 和過敏原的產品。油菜籽卵磷脂由於其非基因改造狀態和無過敏原特性，成為大豆和向日葵卵磷脂等傳統來源的有吸引力的替代品。

根據醫療機構的報告，花生過敏是世界上最常見的食物過敏之一。在西方世界，某些人群的盛行率可能高達每 200 人中就有 1 人患病。在英國，花生過敏者佔總人口的 0.4% 至 0.6%。研究表明，花生過敏約佔兒童所有食物過敏的 28%，並且約一半的病例是在孩子一歲生日之前發生的。 15 歲後很少出現過敏（僅 7% 的病例）。

隨著世界各地的監管機構收緊對基因改造成分和過敏原的法規和標籤要求，製造商面臨著用非基因改造和無過敏原替代品重新配製其產品的壓力。油菜籽卵磷脂滿足這些要求，為製造商提供了符合消費者偏好和監管要求的多功能功能性成分。這導致各行業對油菜籽卵磷脂的需求激增。

人們越來越意識到油菜籽卵磷脂的健康益處

根據美國國立衛生研究院的資料，到2023年，甚至仍有75%的患者超過低密度脂蛋白膽固醇（LDL-C）目標，而高膽固醇血症是最常見、監測最差的心血管危險因子。世界心臟聯盟2023 年報告指出，全球有超過5 億人繼續受到心血管疾病的影響，2021 年心血管疾病死亡人數為2,050 萬人，接近全球死亡人數的三分之一，並且估計的總體死亡人數增加。1.21 億人因心血管疾病死亡。

油菜籽卵磷脂對心血管健康的有益作用是其主要的健康優勢之一。膽固醇和磷脂醯絲胺酸屬於磷脂，存在於油菜籽卵磷脂中，與血管功能、膽固醇水平和脂質代謝的改善有關。對於關心心臟健康的人來說，油菜籽卵磷脂是理想的成分，因為研究表明，經常攝取可能有助於降低心臟病的風險並增強心臟健康。

此外，油菜籽卵磷脂對維持認知健康和大腦功能的貢獻已得到公認。磷脂醯膽鹼是油菜籽卵磷脂的主要成分，是乙醯膽鹼的前體，乙醯膽鹼是對記憶、學習和認知過程至關重要的神經傳導物質。研究表明，食用富含磷脂醯膽鹼的食物，包括油菜籽卵磷脂，可以改善認知功能並降低與年齡相關的認知能力下降的發生率。

油菜籽供應有限且波動

供應限制加劇和油菜籽供應有限是全球油菜籽卵磷脂市場的主要障礙。油菜籽卵磷脂的主要來源是油菜籽，其可用性受到多種變數的影響，例如全球供需動態、天氣模式和耕作技術。乾旱、洪水或蟲害等不利的氣候條件可能會導致油菜籽產量波動，從而降低產量並減少可用於提取卵磷脂的油菜籽數量。

此外，油菜籽是一種商品作物，其種植有多種用途，例如生產石油、動物飼料和生物燃料。其他企業之間對油菜籽的競爭可能會進一步限制其卵磷脂提取的可及性。例如，石油價格的變化可能會影響農民的種植選擇，並導致分配給油籽提取的油菜籽面積相對於其他用途變化。此外，用於生產卵磷脂的油菜籽的可用性可能會受到生物燃料生產成長的影響。

The growing consumer demand for natural, sustainable, and useful ingredients across a range of industries has propelled the steady rise of the global rapeseed lecithin market in recent years. Rapeseed lecithin, which is derived from rapeseed oil, provides an adaptable option for use in food, pharmaceutical, cosmetic, and industrial applications as an emulsifier, stabilizer, and dispersion agent.

According to foodInsight publications, recent data estimate that between 1.1 and 10.8% of the global population has a food allergy, and the rates of food allergies appear to be increasing. Since customers are growing more picky about the contents of their products and are health-conscious, rapeseed lecithin's non-GMO and allergen-free status has made it a desirable substitute for more conventional sources like soy and sunflower lecithin.

The non-GMO rapeseed lecithin accounts largest market share in the global rapeseed lecithin market. Similarly, Asia-Pacific dominates the rapeseed lecithin market, capturing the largest market share of over 1/3rd. As the region's beauty and personal care industry continues to innovate and diversify, rapeseed lecithin offers a desirable ingredient option that meets regulatory requirements and consumer expectations for efficacy, safety, and environmental responsibility.

Dynamics

Increasing Demand for Non-GMO and Allergen-Free Ingredients

Consumers are becoming more conscious of the ingredients used in their food, pharmaceuticals, cosmetics, and industrial products, leading to a preference for cleaner labels and products free from genetically modified organisms (GMOs) and allergens. Rapeseed lecithin serves as an attractive alternative to traditional sources such as soy and sunflower lecithin due to its non-GMO status and allergen-free profile.

According to a medical agency report, peanut allergy is one of the most common food allergies found worldwide. In the Western world, the prevalence can be as high as 1 in 200 individuals in some populations. In the United Kingdom, peanut allergy is present in between 0.4 and 0.6% of the whole population. Studies show that peanut allergy forms around 28% of all food allergies in children and develops before the child reaches their first birthday in about half of cases. The allergy rarely develops after 15 years of age (in only 7% of cases).

As regulatory agencies worldwide tighten regulations and labeling requirements for GMO ingredients and allergens, manufacturers are under pressure to reformulate their products with non-GMO and allergen-free alternatives. Rapeseed lecithin meets these requirements, offering manufacturers a versatile and functional ingredient that aligns with consumer preferences and regulatory mandates. This has led to a surge in demand for rapeseed lecithin across various industries.

Growing Awareness of Health Benefits Associated with Rapeseed Lecithin

According to the National Institute of Health data, In 2023 there are still even 75% of patients over the target of low-density lipoprotein cholesterol (LDL-C), and hypercholesterolemia is the most common and the worst monitored cardiovascular risk factor. The World Heart Federation report of 2023 states that more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021 - close to a third of all deaths globally and an overall increase in the estimated 121 million CVD deaths.

The beneficial effects of rapeseed lecithin on cardiovascular health are among its main health advantages. Cholesterol and phosphatidylserine, which are phospholipids and can be found in rapeseed lecithin, have been associated with improvements in vascular function, cholesterol levels, and lipid metabolism. Rapeseed lecithin is a desirable ingredient for people who are concerned about their heart health because studies indicate that frequent ingestion may help lower the risk of heart disease and enhance heart health.

Moreover, rapeseed lecithin's contribution to maintaining cognitive health and brain function is acknowledged. A primary constituent of rapeseed lecithin, phosphatidylcholine is a precursor to acetylcholine, a neurotransmitter crucial for memory, learning, and cognitive processes. Studies suggest that eating foods high in phosphatidylcholine, including rapeseed lecithin, may improve cognitive function and lower the incidence of age-related cognitive decline.

Limited Availability and Fluctuations in Rapeseed Supply

Raising supply constraints and limited availability of rapeseed are major obstacles to the global market for rapeseed lecithin. The main source of rapeseed lecithin is rapeseed, and its availability is influenced by several variables, such as global supply and demand dynamics, weather patterns, and farming techniques. Unfavorable climatic conditions like droughts, floods, or pest infestations can cause fluctuations in the production of rapeseed, which can lower yields and decrease the amount of rapeseed that is available for lecithin extraction.

Furthermore, rapeseed is a commodity crop that is grown for a variety of uses, such as the production of oil, animal feed, and biofuel. The competition between other businesses for rapeseed may further restrict its accessibility for lecithin extraction. Changes in oil prices, for instance, could affect farmers' planting choices and cause rapeseed acreage allocated to oilseed extraction to change relative to other purposes. Furthermore, the availability of rapeseed for the production of lecithin may be impacted by the growth of biofuel production.

Segment Analysis

The global rapeseed lecithin market is segmented based on origin, form, application, distribution channel and region.

The Surging Demand for Non-GMO Rapeseed Lecithin in the Global Market

Growing consumer awareness of and preference for products with clean labeling is one of the main factors driving the demand for non-GMO rapeseed lecithin. Natural and minimally processed components are in more demand as people grow more health-conscious and picky about the ingredients in their diets, pharmaceuticals, beauty products, and commercial products. This need is met by non-GMO rapeseed lecithin, which provides a non-genetically modified substitute for conventional lecithin sources like soybeans and sunflower seeds.

The increasing use of non-GMO rapeseed lecithin in a variety of product categories can be attributed to this since it is in line with customer demands for natural ingredients, transparency, and sustainability. According to Austrade Inc., research data, interest in non-GMO, allergen-free rapeseed lecithin has grown tremendously over the past decade due to global GMO and allergenic issues in soybeans.

According to a nutraceutical business review published in 2023, economic considerations encourage a switch to rapeseed lecithin by customers. For more than 30 years, rapeseed lecithin has been lower in price than lecithin from other non-GM botanical sources. As a natural product, mostly regionally grown and produced with short transport distances between growers and final customers, rapeseed lecithin also has an attractively low environmental impact.

Geographical Penetration

Rising Tide: Unveiling Asia-Pacific's Appetite for Rapeseed Lecithin Innovation

The expanding food and beverage sector is one of the main factors driving the demand for rapeseed lecithin in the Asia-Pacific region. Demand for processed foods, confectionery, baked goods, and convenience products is rising throughout the Asia-Pacific region as a result of rapid urbanization, changing lifestyles, and rising disposable incomes. In these products, rapeseed lecithin improves texture, appearance, and shelf life by acting as a flexible emulsifier and dispersing agent.

Moreover, according to the National Institutes of Health data, China is the largest producer of rapeseed in the Asia-Pacific region, producing more than 14.7 million tons in 2021. This is more than three times the amount produced by India, the second-largest producer, and 59% of the total volume produced in the region. Japan is the third-largest producer, accounting for 10% of the total volume.

In addition, the Asia-Pacific region's pharmaceutical and nutraceutical sectors support the need for rapeseed lecithin. The market for functional foods, pharmaceutical formulations supplemented with rapeseed lecithin, and dietary supplements is expanding due to an aging population and greater consciousness of health and wellness. The possible health benefits of phospholipids and essential fatty acids found in rapeseed lecithin include support for the cardiovascular system, improvement of cognitive function, and promotion of liver health.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major effect on the global market for rapeseed lecithin, upsetting supply networks, cutting consumer expenditure, and changing consumption habits. Logistical difficulties resulting from movement restrictions and lockdown measures affected the availability and transportation of raw materials needed to produce lecithin.

Furthermore, the pandemic-induced economic slump resulted in decreased demand from sectors including food, medicine, and cosmetics, which affected the total amount of rapeseed lecithin consumed. But despite the crisis, people's concern for their health and well-being grew, which fueled the market for natural and useful components like rapeseed lecithin, especially in industries that valued clean labels and non-GMO products.

Russia-Ukraine War Impact Analysis

The geopolitical instability and conflicts brought about by the Russia-Ukraine war have the potential to upset the global market for rapeseed lecithin. As Ukraine is one of the world's top producers of rapeseed, any interruptions to its ability to manufacture or export could have an effect on the availability of rapeseed lecithin worldwide. Furthermore, Russia is a big player in the rapeseed market, so any escalation of the conflict would cause disruptions to trade and volatility in prices.

Furthermore, changes in sourcing tactics and pricing trends may result from the war's impact on the market dynamics in nearby nations and regions. In order to reduce the risks associated with the Russia-Ukraine conflict, companies in the rapeseed lecithin industry may need to diversify their supply chains and keep an open mind on geopolitical developments.

By Origin

Organic
Conventional
Non-GMO

By Form

Powder
Liquid
Granular
Others

By Application

Food and Beverage
Pharmaceuticals
Cosmetics & Personal Care
Industrial
Others

By Distribution Channel

Supermarkets/Hypermarkets
Online Retail
Specialty Stores
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In November 2023, Sternchemie GmbH & Co. KG expanded its business by focusing on quality and functionality. With its current quality standards, rapeseed has overcome the critical image it once had. By modifying seed and improvement of production and processing steps, rapeseed lecithin has reached the same level as lecithin from other botanical sources.
In December 2021, Sternchemie GmbH & Co. KG introduced new additions to its lecithin product portfolio - the SternInstant and SternPhil series. These are sprayable lecithin blends that are made with soy, rapeseed or sunflower lecithin that can be utilised by manufacters of instant products.
In February 2021, Sternchemie GmbH & Co. KG expanded its portfolio by focusing more on rapeseed, whose functionality is very similar to soy lecithin in many applications. The existing rapeseed portfolio is accordingly being expanded with new solutions that offer full-function alternatives to soy lecithin, especially in situations where flavor and oxidation problems can arise, such as in chocolate or instant products.

Competitive Landscape

The major global players in the market include Cargill, Incorporated, ADM (Archer Daniels Midland Company), Bunge Lecithins, DuPont Nutrition & Biosciences, Lipoid GmbH, American Lecithin Company, Thew Arnott & Co Ltd, Lasenor Emul, Lecico GmbH and Sternchemie GmbH & Co. KG.

Why Purchase the Report?

To visualize the global rapeseed lecithin market segmentation based on origin, form, application, distribution channel, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of rapeseed lecithin market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global rapeseed lecithin market report would provide approximately 70 tables, 66 figures, and 209 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet By Origin
3.2.Snippet by Form
3.3.Snippet by Application
3.4.Snippet by Distribution Channel
3.5.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Increasing Demand for Non-GMO and Allergen-Free Ingredients
  - 4.1.1.2.Growing Awareness of Health Benefits Associated with Rapeseed Lecithin
- 4.1.2.Restraints
  - 4.1.2.1.Limited Availability and Fluctuations in Rapeseed Supply
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Origin

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 7.1.2.Market Attractiveness Index, By Origin
7.2.Organic*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Conventional
7.4.Non-GMO

8.By Form

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2.Market Attractiveness Index, By Form
8.2.Powder*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Liquid
8.4.Granular
8.5.Others

9.By Application

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2.Market Attractiveness Index, By Application
9.2.Food & Beverage*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Pharmaceuticals
9.4.Cosmetics & Personal Care
9.5.Industrial
9.6.Others

10.By Distribution Channel

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2.Market Attractiveness Index, By Distribution Channel
10.2.Supermarkets/Hypermarkets*
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Online Retail
10.4.Specialty Stores
10.5.Others

11.By Region

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2.Market Attractiveness Index, By Region
11.2.North America
- 11.2.1.Introduction
- 11.2.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.6.1.U.S.
- 11.2.6.2.Canada
- 11.2.6.3.Mexico

11.3.Europe
- 11.3.1.Introduction
- 11.3.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.6.1.Germany
- 11.3.6.2.UK
- 11.3.6.3.France
- 11.3.6.4.Italy
- 11.3.6.5.Spain
- 11.3.6.6.Rest of Europe

11.4.South America
- 11.4.1.Introduction
- 11.4.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.6.1.Brazil
- 11.4.6.2.Argentina
- 11.4.6.3.Rest of South America

11.5.Asia-Pacific
- 11.5.1.Introduction
- 11.5.2.Key Region-Specific Dynamics
- 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1.China
  - 11.5.7.2.India
  - 11.5.7.3.Japan
  - 11.5.7.4.Australia
  - 11.5.7.5.Rest of Asia-Pacific
11.6.Middle East and Africa
- 11.6.1.Introduction
- 11.6.2.Key Region-Specific Dynamics
- 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

12.1.Competitive Scenario
12.2.Market Positioning/Share Analysis
12.3.Mergers and Acquisitions Analysis

13.Company Profiles

13.1.Cargill, Incorporated*
- 13.1.1.Company Overview
- 13.1.2.Product Portfolio and Description
- 13.1.3.Financial Overview
- 13.1.4.Key Developments
13.2.ADM (Archer Daniels Midland Company)
13.3.Bunge Lecithins
13.4.DUPONT DE NEMOURS, INC.
13.5.Lipoid GmbH
13.6.American Lecithin Company
13.7.Thew Arnott & Co Ltd
13.8.Lasenor Emul
13.9.Lecico GmbH
13.10.Sternchemie GmbH & Co. KG

LIST NOT EXHAUSTIVE